These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6880125)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1994 Apr; 150(8):1233-9. PubMed ID: 8162546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentration of streptomycin and isoniazid in the blood of patients over 50 with pulmonary tuberculosis after administration of the drugs in ultrasonic aerosols].
    Korablev VN
    Antibiotiki; 1982 Dec; 27(12):53-6. PubMed ID: 7165296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV; Mordyk AV; Zatvornitskiĭ VA; Kondria AV
    Probl Tuberk Bolezn Legk; 2006; (9):45-8. PubMed ID: 17128801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma antioxidative activity in patients with pulmonary tuberculosis].
    Kowalski J; Janiszewska-Drobińska B; Pawlicki L; Cegliński T; Irzmański R
    Pol Merkur Lekarski; 2004 Feb; 16(92):119-22. PubMed ID: 15176293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Side effects of antitubercular drugs in patients with pulmonary tuberculosis and chronic alcoholism].
    Rudoĭ NM; Chubakov TCh
    Sov Med; 1984; (8):7-10. PubMed ID: 6494999
    [No Abstract]   [Full Text] [Related]  

  • 28. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
    Visser ME; Texeira-Swiegelaar C; Maartens G
    Int J Tuberc Lung Dis; 2004 Feb; 8(2):260-2. PubMed ID: 15139457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
    Karachunskiĭ MA; Kaminskaia GO; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (9):25-8. PubMed ID: 15532463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
    Stakhanov VA; Vasil'ev NA; Levi DT; Rukhamina ML
    Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].
    Tashpulatova FK
    Probl Tuberk Bolezn Legk; 2003; (6):17-20. PubMed ID: 12918234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse effects in children receiving short-term chemotherapy for intrathoracic tuberculosis].
    Iukhimenko NV
    Probl Tuberk; 2002; (2):24-7. PubMed ID: 11899799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side effects in pulmonary tuberculosis patients in different chemotherapy methods].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1981 Oct; (10):37-40. PubMed ID: 7312849
    [No Abstract]   [Full Text] [Related]  

  • 35. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum calcium during chemotherapy for active pulmonary tuberculosis.
    Kitrou MP; Phytou-Pallikari A; Tzannes SE; Virvidakis K; Mountokalakis TD
    Eur J Respir Dis; 1983 Jul; 64(5):347-54. PubMed ID: 6884447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Side-effects secondary to antibacterial treatment of patients with pulmonary tuberculosis].
    Tsigelnik AIu; Kostlina ZI; Shapiro VIa; Afanas'ev IV; Grigor'eva VI
    Klin Med (Mosk); 1972 Apr; 50(4):118-22. PubMed ID: 5046181
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and electroencephalographic parallels in patients with tuberculosis of the lungs exhibiting side effects produced by antibacterial preparations].
    Volobueva EG
    Probl Tuberk; 1972; 50(8):31-6. PubMed ID: 5055495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.